Insider Trading activities of Acceleron Pharma Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acceleron Pharma Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acceleron Pharma Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Acceleron Pharma Inc since 2005. The reporting company's ticker symbol is XLRN. The reporting company's CIK number is 1280600.
The total value of stock buying since 2005 is $131,834,909.
The total value of stock sales since 2005 is $216,426,897.
The total value of stock option exercises since 2005 is $9,081,060.


 1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Acceleron Pharma Inc insiders (XLRN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-06-08 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 6,500 32.70 212,537
2015-06-08 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 6,500 3.88 25,220
2015-05-18 Sherman Matthew L (EVP & Chief Medical Officer) Sale 7,000 32.30 226,135
2015-05-18 Sherman Matthew L (EVP & Chief Medical Officer) Option Ex 5,600 2.78 15,567
2015-05-15 Ertel Steven D (EVP & Chief Operating Officer) Sale 2,000 31.45 62,910
2015-05-15 Ertel Steven D (EVP & Chief Operating Officer) Option Ex 2,000 3.88 7,760
2015-05-14 Quisel John D (SVP Gen. Counsel & Secretary) Sale 5,500 31.43 172,892
2015-05-14 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 5,500 5.88 32,340
2015-05-11 Knopf John L (CEO and President) Sale 20,000 32.05 641,100
2015-05-11 Knopf John L (CEO and President) Option Ex 25,000 2.84 71,000
2015-05-11 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 6,500 31.99 207,935
2015-05-11 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 11,500 3.88 44,620
2015-05-08 Ertel Steven D (EVP & Chief Operating Officer) Option Ex 5,000 3.88 19,400
2015-04-20 Sherman Matthew L (EVP & Chief Medical Officer) Sale 5,000 33.52 167,575
2015-04-20 Sherman Matthew L (EVP & Chief Medical Officer) Option Ex 4,000 .48 1,920
2015-04-16 Sherman Matthew L (EVP & Chief Medical Officer) Option Ex 12,000 3.88 46,560
2015-04-15 Ertel Steven D (EVP & Chief Operating Officer) Sale 2,000 33.58 67,160
2015-04-15 Ertel Steven D (EVP & Chief Operating Officer) Option Ex 2,000 3.88 7,760
2015-04-07 Knopf John L (CEO and President) Sale 20,000 35.10 702,060
2015-04-07 Knopf John L (CEO and President) Option Ex 5,000 3.88 19,400
2015-04-07 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 7,000 35.16 246,119
2015-04-07 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 7,000 3.88 27,160
2015-03-18 Sherman Matthew L (EVP & Chief Medical Officer) Sale 6,000 41.31 247,848
2015-03-18 Sherman Matthew L (EVP & Chief Medical Officer) Option Ex 4,800 2.78 13,343
2015-03-16 Quisel John D (SVP Gen. Counsel & Secretary) Sale 5,500 40.94 225,142
2015-03-16 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 5,500 5.88 32,340
2015-03-13 Quisel John D (SVP Gen. Counsel & Secretary) Sale 4,000 41.66 166,660
2015-03-13 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 4,000 5.08 20,320
2015-03-09 Knopf John L (CEO and President) Sale 20,000 40.54 810,800
2015-03-09 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 6,500 40.54 263,529
2015-03-09 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 6,500 3.88 25,220
2015-03-04 Kumar Ravindra (VP & Chief Scientific Officer) Sale 5,500 41.27 226,957
2015-03-04 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 4,000 5.88 23,520
2015-03-04 Quisel John D (SVP Gen. Counsel & Secretary) Sale 9,500 41.40 393,281
2015-03-04 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 9,500 4.25 40,403
2015-03-04 Ertel Steven D (EVP & Chief Operating Officer) Sale 5,000 41.29 206,450
2015-03-04 Ertel Steven D (EVP & Chief Operating Officer) Option Ex 5,000 3.44 17,200
2015-03-04 Sherman Matthew L (EVP & Chief Medical Officer) Sale 7,000 41.04 287,273
2015-03-04 Sherman Matthew L (EVP & Chief Medical Officer) Option Ex 5,600 2.78 15,567
2015-02-09 Knopf John L (CEO and President) Sale 20,000 36.90 737,900
2015-02-09 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 6,500 36.79 239,115
2015-02-09 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 6,500 3.88 25,220
2015-02-02 Kumar Ravindra (VP & Chief Scientific Officer) Sale 5,500 38.88 213,867
2015-02-02 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 4,000 5.88 23,520
2015-02-02 Ertel Steven D (SVP & Chief Business Officer) Sale 5,000 39.10 195,515
2015-02-02 Ertel Steven D (SVP & Chief Business Officer) Option Ex 5,000 1.80 9,000
2015-01-21 Knopf John L (CEO and President) Option Ex 12,500 .40 5,000
2015-01-20 Sherman Matthew L (SVP & Chief Medical Officer) Sale 7,000 41.62 291,368
2015-01-20 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 5,600 2.78 15,567
2015-01-15 Ertel Steven D (SVP & Chief Business Officer) Sale 2,000 40.79 81,580
2015-01-15 Ertel Steven D (SVP & Chief Business Officer) Option Ex 2,000 3.88 7,760
2015-01-14 Quisel John D (SVP Gen. Counsel & Secretary) Sale 9,500 40.20 381,871
2015-01-14 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 9,500 3.79 36,024
2015-01-12 Kumar Ravindra (VP & Chief Scientific Officer) Sale 1,500 40.58 60,862
2015-01-12 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 2,000 40.71 81,420
2015-01-12 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 2,000 3.88 7,760
2015-01-07 Knopf John L (CEO and President) Sale 20,000 39.30 785,900
2015-01-07 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 5,000 39.13 195,650
2015-01-07 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 5,000 3.88 19,400
2015-01-02 Kumar Ravindra (VP & Chief Scientific Officer) Sale 4,000 38.87 155,460
2015-01-02 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 4,000 5.88 23,520
2015-01-02 Ertel Steven D (SVP & Chief Business Officer) Sale 5,000 38.84 194,200
2015-01-02 Ertel Steven D (SVP & Chief Business Officer) Option Ex 5,000 1.80 9,000
2014-12-23 Kania Edwin M Jr (Director) Sale 54,350 38.00 2,065,300
2014-12-19 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 9,810 1.36 13,341
2014-12-19 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 15,000 3.88 58,200
2014-12-18 Sherman Matthew L (SVP & Chief Medical Officer) Sale 5,000 40.31 201,535
2014-12-18 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 4,000 .48 1,920
2014-12-17 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 15,000 3.88 58,200
2014-12-17 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 2,000 3.88 7,760
2014-12-12 Quisel John D (SVP Gen. Counsel & Secretary) Sale 4,000 41.22 164,880
2014-12-12 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 4,000 .92 3,680
2014-12-10 Sherman Matthew L (SVP & Chief Medical Officer) Sale 5,000 43.52 217,615
2014-12-10 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 4,000 5.08 20,320
2014-12-09 George Jean (Director) Sale 8,778 40.11 352,085
2014-12-08 Maniatis Tom Sale 23,400 45.00 1,053,000
2014-12-08 Knopf John L (CEO and President) Sale 20,000 43.36 867,260
2014-12-08 George Jean (Director) Sale 88,629 45.67 4,048,129
2014-12-08 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 10,000 43.68 436,810
2014-12-08 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 10,000 3.88 38,800
2014-12-01 Kumar Ravindra (VP & Chief Scientific Officer) Sale 4,000 36.14 144,548
2014-12-01 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 4,000 5.88 23,520
2014-12-01 Ertel Steven D (SVP & Chief Business Officer) Sale 7,500 36.16 271,177
2014-12-01 Ertel Steven D (SVP & Chief Business Officer) Option Ex 7,500 2.60 19,500
2014-11-18 Sherman Matthew L (SVP & Chief Medical Officer) Sale 5,082 34.00 172,803
2014-11-18 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 4,082 .48 1,959
2014-11-14 Quisel John D (SVP Gen. Counsel & Secretary) Sale 4,000 33.98 135,920
2014-11-14 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 4,000 .92 3,680
2014-11-13 Kumar Ravindra (VP & Chief Scientific Officer) Sale 12,000 35.00 420,000
2014-11-13 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 10,000 5.58 55,800
2014-11-12 Kumar Ravindra (VP & Chief Scientific Officer) Sale 4,000 33.01 132,040
2014-11-12 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 4,000 5.88 23,520
2014-11-12 Quisel John D (SVP Gen. Counsel & Secretary) Sale 5,000 33.01 165,050
2014-11-12 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 5,000 6.50 32,500
2014-11-12 Ertel Steven D (SVP & Chief Business Officer) Sale 10,000 33.04 330,379
2014-11-12 Ertel Steven D (SVP & Chief Business Officer) Option Ex 10,000 2.31 23,070
2014-11-12 Knopf John L (CEO and President) Sale 20,000 33.07 661,400
2014-11-12 Sherman Matthew L (SVP & Chief Medical Officer) Sale 4,918 33.09 162,736
2014-11-12 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 3,918 3.44 13,477
2014-11-12 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 10,000 33.00 330,030
2014-11-12 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 10,000 3.88 38,800
2014-10-31 Maniatis Tom Sale 23,400 40.00 936,000
2014-10-28 Maniatis Tom Sale 17,872 35.00 625,520
2014-10-27 Maniatis Tom Sale 5,528 35.00 193,480
2014-10-27 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 10,000 3.88 38,800
2014-10-20 Sherman Matthew L (SVP & Chief Medical Officer) Sale 4,918 29.11 143,162
2014-10-14 Quisel John D (SVP Gen. Counsel & Secretary) Sale 4,000 29.02 116,080
2014-10-14 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 4,000 .92 3,680
2014-10-08 Knopf John L (CEO and President) Sale 10,000 30.20 302,000
2014-10-08 Sherman Matthew L (SVP & Chief Medical Officer) Sale 5,082 29.78 151,357
2014-10-08 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 4,082 1.80 7,347
2014-10-07 Knopf John L (CEO and President) Sale 10,000 29.22 292,200
2014-10-07 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 10,000 29.25 292,500
2014-10-07 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 10,000 3.88 38,800
2014-10-01 Kumar Ravindra (VP & Chief Scientific Officer) Sale 4,000 29.96 119,860
2014-10-01 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 4,000 5.88 23,520
2014-10-01 Ertel Steven D (SVP & Chief Business Officer) Sale 10,000 29.90 299,030
2014-10-01 Ertel Steven D (SVP & Chief Business Officer) Option Ex 10,000 2.13 21,330
2014-09-30 Kumar Ravindra (VP & Chief Scientific Officer) Sale 7,000 30.00 210,000
2014-09-30 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 5,000 5.58 27,900
2014-09-30 Quisel John D (SVP Gen. Counsel & Secretary) Sale 7,000 30.01 210,070
2014-09-30 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 7,000 6.20 43,400
2014-09-18 Sherman Matthew L (SVP & Chief Medical Officer) Sale 5,000 25.48 127,425
2014-09-12 Quisel John D (SVP Gen. Counsel & Secretary) Sale 2,000 25.43 50,860
2014-09-12 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 2,000 .92 1,840
2014-09-09 Knopf John L (CEO and President) Sale 13,300 24.48 325,517
2014-09-09 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 6,700 24.50 164,116
2014-09-09 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 6,700 3.88 25,996
2014-09-08 Knopf John L (CEO and President) Sale 6,700 24.91 166,930
2014-09-08 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 3,300 24.90 82,170
2014-09-08 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 3,300 3.88 12,804
2014-09-03 Sherman Matthew L (SVP & Chief Medical Officer) Sale 5,000 26.00 129,985
2014-09-03 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 4,000 1.80 7,200
2014-09-02 Kumar Ravindra (VP & Chief Scientific Officer) Sale 2,000 26.40 52,800
2014-09-02 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 2,000 5.88 11,760
2014-09-02 Ertel Steven D (SVP & Chief Business Officer) Sale 10,000 26.43 264,350
2014-09-02 Ertel Steven D (SVP & Chief Business Officer) Option Ex 10,000 2.74 27,400
2014-08-25 Ertel Steven D (SVP & Chief Business Officer) Option Ex 9,000 3.88 34,920
2014-08-18 Sherman Matthew L (SVP & Chief Medical Officer) Sale 2,500 29.77 74,412
2014-08-14 Kumar Ravindra (VP & Chief Scientific Officer) Sale 9,000 29.93 269,325
2014-08-14 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 5,000 5.88 29,400
2014-08-14 Quisel John D (SVP Gen. Counsel & Secretary) Sale 13,000 29.91 388,765
2014-08-14 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 13,000 3.83 49,751
2014-08-14 Ertel Steven D (SVP & Chief Business Officer) Sale 10,000 29.97 299,730
2014-08-14 Ertel Steven D (SVP & Chief Business Officer) Option Ex 10,000 2.74 27,400
2014-08-14 Knopf John L (CEO and President) Sale 17,500 29.78 521,150
2014-08-14 Sherman Matthew L (SVP & Chief Medical Officer) Sale 7,500 29.95 224,602
2014-08-14 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 6,000 1.14 6,839
2014-08-14 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 10,000 29.77 297,750
2014-08-14 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 10,000 3.88 38,800
2014-08-12 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 8,000 1.80 14,400
2014-07-30 Ertel Steven D (SVP & Chief Business Officer) Option Ex 8,000 3.88 31,040
2014-07-23 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 10,000 1.80 18,000
2014-07-18 Sherman Matthew L (SVP & Chief Medical Officer) Sale 2,500 26.22 65,557
2014-07-14 Quisel John D (SVP Gen. Counsel & Secretary) Sale 5,000 29.51 147,550
2014-07-14 Quisel John D (SVP Gen. Counsel & Secretary) Option Ex 5,000 3.10 15,500
2014-07-09 Sherman Matthew L (SVP & Chief Medical Officer) Sale 7,500 29.04 217,815
2014-07-09 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 6,000 .48 2,880
2014-07-07 Knopf John L (CEO and President) Sale 17,500 32.02 560,402
2014-07-07 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 10,000 31.99 319,930
2014-07-07 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 10,000 3.88 38,800
2014-07-01 Kumar Ravindra (VP & Chief Scientific Officer) Sale 2,000 34.10 68,200
2014-07-01 Ertel Steven D (SVP & Chief Business Officer) Sale 10,000 34.09 340,950
2014-07-01 Ertel Steven D (SVP & Chief Business Officer) Option Ex 10,000 2.74 27,400
2014-06-30 Maniatis Tom Sale 41,000 34.14 1,399,740
2014-06-26 George Jean (Director) Sale 10,320 35.01 361,303
2014-06-25 George Jean (Director) Sale 171 35.00 5,985
2014-06-24 George Jean (Director) Sale 10,402 35.03 364,382
2014-06-23 George Jean (Director) Sale 13,618 35.27 480,306
2014-06-20 Kumar Ravindra (VP & Chief Scientific Officer) Sale 7,000 35.00 245,000
2014-06-20 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 5,000 5.88 29,400
2014-06-20 George Jean (Director) Sale 1,457 35.02 51,024
2014-06-18 Sherman Matthew L (SVP & Chief Medical Officer) Sale 2,500 34.31 85,775
2014-06-17 Ertel Steven D (SVP & Chief Business Officer) Option Ex 8,000 3.88 31,040
2014-06-13 Quisel John D (VP General Counsel & Secretary) Sale 9,000 33.99 305,955
2014-06-13 Quisel John D (VP General Counsel & Secretary) Option Ex 9,000 3.36 30,240
2014-06-11 Sherman Matthew L (SVP & Chief Medical Officer) Sale 7,500 33.24 249,300
2014-06-11 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 6,000 .48 2,880
2014-06-09 Knopf John L (CEO and President) Sale 15,000 31.57 473,625
2014-06-09 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 10,000 31.58 315,780
2014-06-09 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 10,000 3.88 38,800
2014-06-02 Kumar Ravindra (VP & Chief Scientific Officer) Sale 2,000 29.72 59,440
2014-06-02 Ertel Steven D (SVP & Chief Business Officer) Sale 10,000 29.83 298,270
2014-06-02 Ertel Steven D (SVP & Chief Business Officer) Option Ex 10,000 2.74 27,400
2014-05-28 Sherman Matthew L (SVP & Chief Medical Officer) Sale 7,500 30.98 232,350
2014-05-28 Sherman Matthew L (SVP & Chief Medical Officer) Option Ex 6,000 .48 2,880
2014-05-19 Kumar Ravindra (VP & Chief Scientific Officer) Sale 9,000 31.79 286,065
2014-05-19 Kumar Ravindra (VP & Chief Scientific Officer) Option Ex 5,000 5.88 29,400
2014-05-19 Quisel John D (VP General Counsel & Secretary) Sale 9,000 31.66 284,940
2014-05-19 Quisel John D (VP General Counsel & Secretary) Option Ex 9,000 2.40 21,600
2014-05-19 Ertel Steven D (SVP & Chief Business Officer) Sale 10,000 31.88 318,780
2014-05-19 Ertel Steven D (SVP & Chief Business Officer) Option Ex 10,000 2.74 27,400
2014-05-19 Knopf John L (CEO and President) Sale 15,000 31.86 477,855
2014-05-19 Sherman Matthew L (SVP & Chief Medical Officer) Sale 2,500 31.79 79,482
2014-05-19 Mclaughlin Kevin F (SVP, CFO and Treasurer) Sale 10,000 31.85 318,530
2014-05-19 Mclaughlin Kevin F (SVP, CFO and Treasurer) Option Ex 10,000 3.88 38,800
2014-05-05 George Jean (Director) Sale 215,644 42.86 9,242,501
2014-05-05 Kania Edwin M Jr (Director) Sale 215,142 42.86 9,220,986
2014-05-05 Polaris Venture Partners Iv Lp (10% Owner) Sale 313,491 42.86 13,436,224
2014-05-05 Mcguire Terrance (Director) Sale 313,491 42.86 13,436,224
2014-05-05 Celgene Corp /de/ (10% Owner) Buy 1,100,000 42.86 47,146,000
2014-04-24 Kania Edwin M Jr (Director) Sale 854,618 31.45 26,877,736
2014-04-23 Kania Edwin M Jr (Director) Sale 23,700 33.81 801,297
2014-04-22 Kumar Ravindra (VP & Chief Scientific Officer) Sale 2,000 35.86 71,720
2014-04-22 Quisel John D (VP General Counsel & Secretary) Sale 2,000 35.94 71,880
2014-04-22 Quisel John D (VP General Counsel & Secretary) Option Ex 2,000 .92 1,840
2014-04-22 Ertel Steven D (SVP & Chief Business Officer) Sale 2,500 35.96 89,900
2014-04-22 Ertel Steven D (SVP & Chief Business Officer) Option Ex 2,500 .40 1,000
2014-04-22 Sherman Matthew L (SVP & Chief Medical Officer) Sale 5,000 35.82 179,115
2014-04-22 Kania Edwin M Jr (Director) Sale 121,682 35.89 4,367,166
2014-01-28 Celgene Corp /de/ (10% Owner) Buy 300,000 50.00 15,000,000
2013-09-24 Celgene Corp /de/ (10% Owner) Buy 666,667 15.00 10,000,005
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of XLRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acceleron Pharma Inc (symbol XLRN, CIK number 1280600) see the Securities and Exchange Commission (SEC) website.